AAN: Tolebrutinib Slows Disability in Nonrelapsing Secondary Progressive MS

WEDNESDAY, April 9, 2025 -- Tolebrutinib, a brain-penetrant and bioactive Bruton tyrosine kinase inhibitor that modulates persistent immune activation within the central nervous system, slows disability progression in adults with nonrelapsing...

Related Posts

Lithium Linked to Risk for Thyroid Dysfunction, CKD in ...

Feb 12, 2025  0

Tenecteplase Is Reasonable Alternative to Alteplase for...

Mar 24, 2025  0

Pelabresib Plus Ruxolitinib Improves Underlying Myelofi...

Mar 27, 2025  0

Comments

Name

Email

Comment

Post Comment